(6S)-6-benzyl-1-(1H-indol-4-ylmethyl)-4-(5-methoxy-1H-indole-2-carbonyl)piperazin-2-one
C30H28N4O3 — CID 122600578
Data last refreshed: (MolForge compound catalog, from PubChem)
About (6S)-6-benzyl-1-(1H-indol-4-ylmethyl)-4-(5-methoxy-1H-indole-2-carbonyl)piperazin-2-one
(6S)-6-benzyl-1-(1H-indol-4-ylmethyl)-4-(5-methoxy-1H-indole-2-carbonyl)piperazin-2-one (PubChem CID 122600578) has the molecular formula C30H28N4O3 and a molecular weight of 492.58 g/mol. Its IUPAC name is (6S)-6-benzyl-1-(1H-indol-4-ylmethyl)-4-(5-methoxy-1H-indole-2-carbonyl)piperazin-2-one.
Molecular Properties
| Compound Name | (6S)-6-benzyl-1-(1H-indol-4-ylmethyl)-4-(5-methoxy-1H-indole-2-carbonyl)piperazin-2-one |
|---|---|
| PubChem CID | 122600578 |
| Molecular Formula | C30H28N4O3 |
| Molecular Weight | 492.58 g/mol |
| Exact Mass | 492.22 |
| IUPAC Name | (6S)-6-benzyl-1-(1H-indol-4-ylmethyl)-4-(5-methoxy-1H-indole-2-carbonyl)piperazin-2-one |
| SMILES | COc1ccc2[nH]c(C(=O)N3CC(=O)N(Cc4cccc5[nH]ccc45)[C@@H](Cc4ccccc4)C3)cc2c1 |
| InChI | InChI=1S/C30H28N4O3/c1-37-24-10-11-26-22(15-24)16-28(32-26)30(36)33-18-23(14-20-6-3-2-4-7-20)34(29(35)19-33)17-21-8-5-9-27-25(21)12-13-31-27/h2-13,15-16,23,31-32H,14,17-19H2,1H3/t23-/m0/s1 |
| InChIKey | BLHPRUGHLURPEC-QHCPKHFHSA-N |
| XLogP | 4.75 |
| TPSA | 81.43 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 492.58 |
| LogP ≤ 5 | 4.75 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122600578 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.